Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
ForSight VISION5
is defunct.
Acquired by Allergan, Aug 2016, $95M
------------------
If you believe any of this information is incorrect, please
let us know
.